0006-3061Level 3
EMEND (FOSAPREPITANT DIMEGLUMINE)
**Product type:** Human Prescription Drug
**Active ingredient:** FOSAPREPITANT DIMEGLUMINE
**Strength:** 150 mg/5mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Merck Sharp & Dohme LLC
**Marketing category:** NDA (NDA022023)
**Pharmacologic class:** Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0006-3061Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.